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Detecting transcription of ribosomal protein
pseudogenes in diverse human tissues from
RNA-seq data
Peter Tonner1, Vinodh Srinivasasainagendra2, Shaojie Zhang1* and Degui Zhi2*

Abstract
Background: Ribosomal proteins (RPs) have about 2000 pseudogenes in the human genome. While anecdotal
reports for RP pseudogene transcription exists, it is unclear to what extent these pseudogenes are transcribed. The
RP pseudogene transcription is difficult to identify in microarrays due to potential cross-hybridization between
transcripts from the parent genes and pseudogenes. Recently, transcriptome sequencing (RNA-seq) provides an
opportunity to ascertain the transcription of pseudogenes. A challenge for pseudogene expression discovery in
RNA-seq data lies in the difficulty to uniquely identify reads mapped to pseudogene regions, which are typically
also similar to the parent genes.
Results: Here we developed a specialized pipeline for pseudogene transcription discovery. We first construct a
“composite genome” that includes the entire human genome sequence as well as mRNA sequences of real
ribosomal protein genes. We then map all sequence reads to the composite genome, and only exact matches were
retained. Moreover, we restrict our analysis to strictly defined mappable regions and calculate the RPKM values as
measurement of pseudogene transcription levels. We report evidences for the transcription of RP pseudogenes in
16 human tissues. By analyzing the Human Body Map 2.0 study RNA-sequencing data using our pipeline, we
identified that one ribosomal protein (RP) pseudogene (PGOHUM-249508) is transcribed with RPKM 170 in thyroid.
Moreover, three other RP pseudogenes are transcribed with RPKM > 10, a level similar to that of the normal RP
genes, in white blood cell, kidney, and testes, respectively. Furthermore, an additional thirteen RP pseudogenes are
of RPKM > 5, corresponding to the 20–30 percentile among all genes. Unlike ribosomal protein genes that are
constitutively expressed in almost all tissues, RP pseudogenes are differentially expressed, suggesting that they may
contribute to tissue-specific biological processes.
Conclusions: Using a specialized bioinformatics method, we identified the transcription of ribosomal protein
pseudogenes in human tissues using RNA-seq data.
Keywords: Ribosomal protein, Pseudogene, Transcription, RNA-seq data

Background
Pseudogenes are “fossil” copies of functional genes that
have lost their potential as DNA templates for functional
products [1-6]. While the definition of pseudogenes is
still somewhat fuzzy, most of them are defined operationally by bioinformatics criteria, e.g., genomic scans
of signatures of homology to known genes. Ribosomal
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1
Department of Electrical Engineering and Computer Science, University of
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protein (RP) pseudogenes represent the largest class of
pseudogenes found in the human genome: over 2000
ribosomal protein pseudogenes are identified by bioinformatics scan of genomic sequence [5].
These pseudogenes are commonly thought to be nonfunctional due to the lack of promoters and/or the presence of loss of function mutations. Indeed, the vast
majority of these pseudogenes either carry dysfunctional
mutations such as in-frame stop codons, or lack of
proper regulatory sequences, such as promoters, mTOP
signals, and first introns [7]. Interestingly, three RP
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Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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pseudogenes, with 89%-95% sequence identity to their
parent (progenitor) RP genes, were found to be transcribed and seem to be functional, by a bioinformatics
scan of cDNA and expression sequence tag (EST) databases and confirmation by PCR and Northern blot [8]. A
genome-wide bioinformatics scan identified over 2000
potential pseudogenes [5]. Moreover, it was found [9]
that the six RP pseudogenes shared at syntenic loci between the human and the mouse genomes are more
conserved than other RP pseudogenes.
However, data were lacking to experimentally validate
pseudogene expression. It is unclear from the literature
whether the reported cases are merely anecdotal or that
pseudogenes do play some cellular roles. This is largely
hindered by the lack of methods for the identification of
pseudogenes transcription. The traditional method of
transcriptome profiling, gene expression microarray, is
not sensitive in distinguishing transcripts among very
similar gene sequences.
Recent advancements of next-generation sequencing
allow for direct massive transcriptome sequencing
(RNA-seq), and thus providing unprecedented insights
into all transcribed sequences. For example, RNA-seq
has been applied to detect complex transcriptional activities such as alternative splicing [10,11] and allelicspecific expression [12]. Recently, RNA-seq has been
applied to reveal RNA editing events [13]. However, to the

best of our knowledge, there were yet no attempts to detect the transcription of pseudogenes in RNA-seq data.
The main challenge for pseudogene identification in
RNA-seq data is the difficulty of high fidelity read mapping. Because sequences of pseudogenes are highly similar
to the sequences of the mRNAs of the parent genes, specialized read mapping methods are required to detect
reads unambiguously generated from pseudogenes.
In this study, we conduct a bioinformatics analysis of
pseudogene expression using RNA-sequencing data of 16
human tissues of the Illumina Human Body Map 2.0 project. We first describe our new computational pipeline for
detecting pseudogene expression that disentangles sequencing reads of pseudogenes from those of the parent
genes, with consideration of possible mismatches due to
SNPs and RNA-editing. This is followed by a description
of our findings and a discussion of their implications.

Results
Illumina Human Body Map 2.0 RNA-seq data

The Human Body Map 2.0 Project by Illumina generated
RNA-seq data for 16 different human tissues (adipose,
adrenal, brain, breast, colon, heart, kidney, liver, lung,
lymph node, ovary, prostate, skeletal muscle, testes, thyroid, and white blood cells). In our analysis we used the
75 bps single read data, with one lane of HiSeq 2000

Table 1 The number of reads mapped to RefSeq sequences and RP pseudogenes for both the composite genome and
the unaltered human genome (hg18) for each tissue
Tissue

RP Pseudogenes

RefSeq Sequences

Composite genome

hg18

Ratio

Composite genome

Adipose

708

22613

0.03

22018081

Adrenal

hg18
23753007

Ratio
0.93

2439

22280

0.11

19436010

21074345

0.92

Brain

712

3853

0.18

11585759

12357788

0.94

Breast

1603

15951

0.10

22962845

23060856

1.00

Colon

1066

22948

0.05

21458813

21618780

0.99

Heart

562

2374

0.24

12622175

13502482

0.93

Kidney

1341

5928

0.23

20630500

22278600

0.93

Liver

328

2359

0.14

16689110

17958332

0.93

Lung

1128

11918

0.09

28648503

31274037

0.92

Lymph

1456

14010

0.10

22126747

23998836

0.92

Muscle

459

8705

0.05

25836676

27662752

0.93

Ovary

1501

34608

0.04

21842763

23663484

0.92

Prostate

1280

14976

0.09

30329651

32822472

0.92

Testes

1885

19417

0.10

23356973

25123824

0.93

Thyroid

4064

22250

0.18

24800037

26627946

0.93

White Blood Cells

1095

14256

0.08

25487259

27812790

0.92

Average

1351

14902

0.11

21864493

23411895

0.94

The ratio is calculated by the number of mapped reads from the composite genome over the number of mapped reads from the unaltered human genome
(hg18).
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data per tissue. Standard mRNA-seq library preps were
used to extract poly-A selected mRNAs.
Discovery of pseudogene transcription in RNA-seq data

Our primary goal is to detect transcriptional activities of
any of the 1709 processed RP pseudogenes. In addition,
we also want to provide a preliminary quantification of
their level of transcription.
We developed a novel bioinformatics approach for
detecting the subtle signals of pseudogene expression.
Briefly, we first compiled a “composite genome” consisting
of known RP gene spliced mRNA sequences and the
human genome (hg18) [14]. We then mapped RNA-seq
reads to the composite genome using Bowtie [15], allowing
no mismatches and discarding reads mapped to more than
one locus. Thus we ensured that the reads mapped to RP
pseudogenes are neither from repetitive regions nor from
normal RP genes. On average 89% of the reads aligning to
RP pseudogenes can also be mapped to real RP spliced
mRNA sequences and are removed when mapped to the
composite genome (see Table 1). Furthermore, to remove
mapped reads that may be caused by SNPs and RNAediting, we extended the concept of the mappability (the
mappable regions of human genome is called the
uniqueome) [16] and masked regions in RP pseudogenes
that are duplicated in the composite genome within 4 mismatches over the 75 bps read length. The number of reads

we removed from non-unique locations in both the composite genome and hg18 genome can be seen in Table 2.
The mappability regions only correspond to the unaltered
human genome locations, so all reads mapped to RP gene
mRNA sequences in the composite genome are removed
during this step. Additionally, the composite genome alignment lacks the reads that mapped both to the unaltered
human genome locations and spliced RP gene mRNA
sequences as we only retained reads aligning to a single location. With both of these groups of reads removed, the
number of reads mapped uniquely in the composite genome is always less than that in the unaltered human genome. Finally, we calculated the transcription levels, as
measured by the Reads Per Kilobase per Million reads
(RPKM) [11] of all pseudogenes according to the mapped
reads in their mappable regions. As a benchmark for normal expression levels, we also aligned reads to an unaltered
genome using TopHat and measured FPKM of all RefSeq
genes using Cufflinks [17]. The alignment information of
reads to the composite genome, and to the unaltered genome (hg18), can be seen in Table 2. Please see Methods for
details.
Prevalent transcription of RP pseudogenes

The expression levels of the top seventeen highly
expressed ribosomal protein pseudogenes in 16 human
tissues are shown in Figure 1 and Table 3 (See Table S1

Table 2 Statistics for each tissue sample
Tissue

Number of
reads in the
sample

Number of
reads mapped
to the
composite
genome

Number of
reads
mapped to
hg18

Number of reads
mapped uniquely
to the composite
genome

Number of
reads mapped
uniquely to the
hg18

Adipose

76,269,225

39,499,413

39,759,404

27,507,408

30,635,265

Adrenal

76,171,569

39,330,423

39,681,721

29,670,249

32,603,673

Brain

64,313,204

21,022,913

21,073,103

15,785,362

17,187,772

Breast

77,195,260

39,355,808

39,568,435

30,955,674

31,072,723

Colon

80,257,757

39,406,195

39,735,900

28,393,105

28,582,515

Heart

76,766,862

29,030,896

29,065,063

17,099,881

19,366,541

Kidney

79,772,393

41,368,095

41,488,175

27,316,562

30,570,744

Liver

77,453,877

26,692,219

26,741,073

18,897,673

20,715,729

Lung

81,255,438

45,996,752

46,211,355

34,401,958

37,862,617

Lymph

81,916,460

41,826,888

42,072,585

30,451,248

33,277,288

Muscle

82,864,636

46,580,440

46,725,392

30,704,302

34,165,828

Ovary

81,003,052

36,922,138

37,385,453

28,184,877

30,861,571

Prostate

83,319,902

47,601,661

47,965,443

36,138,822

39,533,973

Testes

82,044,319

38,852,709

39,069,136

29,115,004

31,927,737

Thyroid

80,246,657

40,546,781

40,785,090

31,137,501

33,939,339

White Blood Cells

82,785,673

38,860,771

39,098,752

28,796,204

31,784,122

The number of reads mapped to the composite genome (which includes spliced ribosomal protein gene sequences) and to the unaltered human genome (hg18),
and the number of reads overlapped with uniqueome (“mapped uniquely”) for both are shown. For the composite genome, the number of reads aligning to the
entire composite genome and the unaltered hg18 human genome are shown.
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Figure 1 RPKM of RP pseudogenes. See Table S1 in Additional file 1 for the complete list.

in Additional file 1 for complete list for all RP pseudogenes). As expected the majority of pseudogenes have
no reads aligning to their sequence. Interestingly, there
were some pseudogenes with high expression levels.
One RP pseudogene (PGOHUM-249508) is transcribed
with RPKM 170 in thyroid. Moreover, three additional
RP pseudogenes are transcribed with RPKM > 10. Furthermore, thirteen more RP pseudogenes are of RPKM > 5.
We describe pseudogenes with an RPKM > 10 as “highly
expressed”, with the understanding that they may be
only representing the top 10–15 percentile of all 37,681
RefSeq genes in the Human Body Map 2.0 data set,
while RPKM > 5 represents the top 20–30 percentile
(see Table 4). Below we discuss these cases in detail.
PGOHUM-249508, an RPL21 pseudogene, is expressed
with RPKM = 170 in thyroid (Figure 2). This highest
expressed RP pseudogene is located in an intron of the
Thyroglobulin (TG) gene. The TG gene is highly and specifically expressed in the same tissue, thyroid, and the gene
encodes a glycoprotein that acts as a substrate for the

synthesis of thyroxine and triiodothyronine as well as the
storage of the inactive forms of thyroid hormone and iodine [18]. The transcription of this pseudogene goes beyond
the annotated pseudogene region, but is less than the entire intron region. Although the pseudogene is specifically
expressed in the same tissue as TG, the RP coding frame
is on the reverse strand of the TG gene. Therefore, it is
possible that this pseudogene is on a distinct transcript
other than the TG gene. Moreover, according to UCSC
genome browser [19], this pseudogene region is only
conserved within the primates (between human and the
Rhesus monkey), but not in other mammalian and vertebrate lineages. As a side note, the genome browser shows
a peculiar conservation pattern between human and the
stickleback fish, but it is likely to be an artifact of matching human genomic sequence with the RPL21 gene of
stickleback fish.
Three additional pseudogenes are highly transcribed
(RPKM > 10). PGOHUM-237215, an RPL7A pseudogene,
is expressed RPKM = 17 in white blood cells. This
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Table 3 RP pseudogenes expression identified in Human Body Map 2.0 RNA-seq data
pg-id

Parent gene

Location

Tissue with Max RPKM

249508

RPL21

chr8:134084035-134084502

Thyroid

Max RPKM

Total RPKM

Tissue specificity

Reads coverage

170.3

170.6

0.977

0.976

237215

RPL7A

chr17:6984988-6985635

White Blood Cells

17.3

18.0

0.881

0.913

249146

RPS24

chr16:55497947-55498335

Kidney

16.5

17.6

0.855

0.693

239833

RPS11

chr12:63076580-63077044

Testes

11.3

12.5

0.813

0.970

236635

RPL24

chr9:72021934-72022269

Colon

9.7

9.7

1.000

0.358

248697

RPL26

chr16:1953719-1954097

Lymph

9.0

37.9

0.376

0.854

242376

RPS20

chr11:77202016-77202370

Colon

8.6

41.6

0.355

1.00

251340

RPLP1

chr5:151125656-151125993

Testes

7.4

40.1

0.339

0.567

237777

RPL7

chr3:133445060-133445787

Prostate

7.3

8.0

0.819

0.371

234492

RPL10

chr19:9791817-9792131

Brain

7.2

10.8

0.635

0.121

248932

RPL21

chr16:72904438-72904782

Ovary

6.5

34.3

0.343

1.00

234407

RPL39

chr19:58143205-58143330

Colon

6.3

21.3

0.414

1.00

239633

RPL13

chr12:6863424-6864038

Kidney

6.0

27.0

0.365

0.923

245936

RPL6

chr4:66121772-66122638

Colon

5.9

7.2

0.746

0.109

243590

RPL32

chr6:33155206-33155612

Adrenal

5.8

9.2

0.617

1.00

241074

RPL13A

chr2:203093361-203093957

Lung

5.4

9.7

0.571

0.995

238877

RPL11

chr10:89695235-89695766

Adipose

5.2

20.4

0.387

0.847

Expression levels of pseudogenes with their pseudogene ID (pg-id, prefix ‘PGOHUM00000’ omitted) are measured in terms of RPKM. Only pseudogenes with
maximum RPKM > 5 are shown. Tissue specificities are measured by the JS divergence [20]. Read coverage is the ratio of pseudogene exon length covered by
uniquely mapped reads to the total pseudogene exon length.

pseudogene is located in an intergenic region. Also, the
transcription unit seems to span a longer region
(Figure 3). It is transcribed in a white blood cell specific
fashion. PGOHUM-249146, an RPS24 pseudogene, is
expressed in kidney. This pseudogene is located in the intronic region of gene SLC12A3 (Figure 4). This gene
encodes a renal thiazide-sensitive sodium-chloride

cotransporter that is important for electrolyte homeostasis. PGOHUM-239833, an RPS11 pseudogene, is
expressed in testes. This pseudogene is located in an intergenic region (Figure 5). The comparison of read coverage
with or without uniqueome filtering for these four RP
pseudogenes can be been in Figures S1-S4 in Additional
file 2.

Table 4 Table of FPKM expression values of RefSeq genes in 16 human tissues
Tissue

FPKM

Percentile

Mean

Max

Min

std dev

%>1

%>2

%>5

% > 10

% > 15

Adipose

10.03

17437.80

0

143.53

41.07

32.42

20.62

12.64

8.96

Colon

10.42

17376.90

0

167.07

40.80

31.61

19.67

11.93

8.37

Heart

7.55

17376.90

0

122.87

36.61

27.71

16.09

9.41

6.43

Kidney

9.97

16400.20

0

156.94

45.28

35.93

22.62

13.32

9.23

Liver

14.91

38505.10

0

360.25

33.57

25.10

14.90

8.93

6.48

Lung

16.29

57096.60

0

456.70

44.59

35.08

22.05

13.61

9.72

Lymph

13.41

40919.80

0

337.50

45.77

36.77

23.25

13.70

9.22

Muscle

8.80

16317.70

0

123.85

33.27

25.97

16.38

10.39

7.55

Ovary

13.62

61099.30

0

359.00

46.27

37.60

24.59

15.05

10.37

Prostate

13.72

39039.90

0

300.91

47.82

38.83

25.36

15.68

10.79

Testes

12.76

57096.60

0

325.41

53.34

43.44

28.69

17.85

12.46

Thyroid

12.06

29030.10

0

234.59

46.04

37.25

24.24

15.12

10.74

White Blood Cells

15.42

40919.80

0

366.35

39.25

32.56

22.65

14.87

10.83

All Tissues

12.23

61099.30

0

286.98

42.59

33.87

21.62

13.27

9.32

Percentile columns represent the percentage of RefSeq genes in all tissues with FPKM above a given value.
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Figure 2 UCSC browser view of RNA-seq expression of pseudogene PGOHUM-249508 in Thyroid. RPKM = 170, Tissue Specificity = 0.977.
Open reading frames (ORFs) in +1, +2, +3, -1, -2, and −3 are annotated.

Tissue-specificity of pseudogene transcription

Many genes are expressed in a tissue-specific fashion.
The Human Body Map 2.0 data allow us to study the
tissue-specificity of transcriptions of these pseudogenes.
We adopt the entropy-based Jensen-Shannon (JS) divergence measure used in [20]. The distributions of tissuespecificity JS divergences of RP pseudogenes versus RP
genes are shown in Figure 6. In the Human Body Map
2.0 data set, all RP genes are not transcribed in a tissue
specific fashion (JS divergence <0.5 for all RP genes)
(Table S2 in Additional file 3). Unlike ribosomal protein
genes that are constitutively expressed in almost all tissues, many RP pseudogenes are differentially expressed
(Table S1 in Additional file 1). Among the seventeen
pseudogenes with RPKM > 5 at some tissue, 8 of them
have a JS divergence > 0.5. In fact, all of the top 4 pseudogenes with RPKM > 10 are transcribed in a highly tissue specific fashion (JS divergence > 0.8). These results
suggest that these highly expressed RP pseudogenes may
contribute to tissue-specific biological processes.

Discussion and conclusions
In this work, we conducted a bioinformatics analysis of
the pseudogenes of ribosomal protein genes in diverse
human tissues. Using our specialized pipeline, we identified several cases of pseudogene expression. Most notably, one pseudogene in an intron of the TG gene is
extremely highly expressed in thyroid. Moreover, several
other pseudogenes are also highly expressed. We found
that many pseudogenes are expressed in a tissue-specific
fashion. Also, the expression of pseudogenes seems to
often go beyond the boundaries of the annotated pseudogenes. Apparently, further experimental investigations
will be needed to reveal the biological relevance of these
expressions.
Transcriptome sequencing, RNA-seq, provides an unprecedented opportunity to uncover many complexities
of cellular gene expression. A key computational challenge in RNA-seq data analysis is to discern reads among
multiple potential sources with similar sequences. In this
work we focused on the detection of evidences of
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Figure 3 UCSC browser view RNA-seq expression of pseudogene PGOHUM-237215 in white blood cells. RPKM = 17, Tissue
Specificity = 0.881. Open reading frames (ORFs) in +1, +2, +3, -1, -2, and −3 are annotated.

pseudogene expression. We used extremely strict read
mapping criteria to minimize potential false positives.
Admittedly we did not utilize all potential reads, especially
at regions with low uniqueness. Further research may consider using looser mapping criteria combined with sophisticated statistical algorithms to take into account the
mapping ambiguity.
The bioinformatics methods presented here may find
application in other RNA-seq studies dealing with high
similarity in reference sequences. In particular, the same
methodology may be able to identify differential expression between other homologous genome regions. Studies in other fields, such as metagenomics, dealing with
high similarity DNA sequences may also find benefits
from strict alignment and intersection with uniquely
mappable locations.

Methods
Human tissue samples

The Human Body Map 2.0 RNA-seq data for 16 human tissue samples were provided by Gary Schroth at Illumina
and can be accessible from ArrayExpress (accession no. EMTAB-513). Reads were 75 base pairs long and came from
the following samples: adipose, adrenal, brain, breast, colon,
heart, kidney, liver, lung, lymph, muscle, ovary, prostate,
testes, thyroid, and white blood cells. The samples were
prepared using the Illumina mRNA-seq kit. They were
made with a random priming process and are not stranded.
Software and datasets

Bowtie version 0.12.7 [15] and TopHat version 1.2.0 [21]
were used for the mapping. Cufflinks version 1.0.3 [17]
was used for differential expression calculation for
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Figure 4 UCSC browser view RNA-seq expression of pseudogene PGOHUM-249146 in kidney. RPKM = 16, Tissue Specificity = 0.855. Open
reading frames (ORFs) in +1, +2, +3, -1, -2, and −3 are annotated.

RefSeq genes. BEDTools version 2.12.0 [22] was used to
analyze alignments. The uniqueome dataset was collected from the Uniqueome supplementary database [16]
for human genome (hg18, NCBI Build 36.1) marking
genome locations where reads of length 75 bps
are unique within 4 mismatches (hg18_uniqueome.
unique_starts.base-space.75.4.positive.BED). The 75 bps
read length matches the RNA-seq data provided by Illumina. RefSeq genes and DNA sequences of spliced ribosomal protein genes were collected from NCBI (RefSeq
database D32-6) [14]. Pseudogene annotations and
sequences were downloaded from pseudogene.org [23]
database (human pseudogenes build 58). Pseudogenes
whose parent genes are ribosomal protein genes were

selected, totaling 1788. Among them, 79 were annotated
‘Duplicated’. As we are only interested in processed
pseudogenes, our analysis focuses on the remaining
1709 pseudogenes. The human genome sequence (hg18)
was collected from NCBI build 36.1.
Composite genome

A composite genome index was constructed with Bowtiebuild using the sequences of the human genome (hg18,
NCBI build 36.1) and NCBI spliced RP gene sequences.
Alignment

RNA-seq data for each tissue was aligned using two distinct
methodologies – one for pseudogenes and one for real
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Figure 5 UCSC browser view RNA-seq expression of pseudogene PGOHUM-239833 in testes. RPKM = 11, Tissue Specificity = 0.813. Open
reading frames (ORFs) in +1, +2, +3, -1, -2, and −3 are annotated.

genes. Pseudogene alignment protocol consists of strict
alignment (Bowtie, no mismatches, report reads with only
one alignment location only) to the composite genome.
Real gene alignment protocol consists of strict alignment
(Bowtie, no mismatches, single alignment location) to the
human genome (hg18, NCBI Build 36.1).
Uniqueome

A uniqueome data set [16] was obtained for Build 36.1
marking genome locations where reads of length 75 bps
are unique within 4 mismatches. Alignments for all tissues for both real genes and pseudogenes were intersected with the uniqueome dataset for all genome
locations (intersectBed from BEDTools [22]). The total

number of remaining reads in each alignment was
counted. The uniqueome dataset was used to filter out
ambiguously mapped reads.
Comparative expression analysis

Gene expression values were calculated as reads
aligned to gene per kilobase of exon per million
mapped reads (RPKM) [11]. The number of reads
aligned to all gene exons and additionally aligning in
unique locations was counted for each gene. Exon
length for genes was calculated as the sum of unique
positions as marked by the uniqueome across all gene
exons. It is worth noting that RP pseudogenes appear
spliced in the human genome and therefore have only
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Figure 6 Distribution of tissue specificity, as measured by the
JS divergence [20].

a single exon for counting aligned reads and calculating exon length.
Expression percentiles of RefSeq genes were calculated
using TopHat to map reads to the human genome (hg18,
NCBI build 36.1) and Cufflinks was used to calculate
FPKM values of all 37,681 RefSeq genes. Expression percentiles were calculated for specific tissues and for all
datasets combined.
Gene reads coverage was calculated using the coverageBed program in the BEDTools software suite. Coverage
represents the fraction of RP pseudogene exon covered by
reads that aligned to unique genome regions.
Tissue-specificity analysis

We followed the definition of Jensen-Shannon divergence in [20]. To avoid zero probabilities, all RPKM
numbers are added by 10-10.
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